Pure Global

Qualitative test reagents for CD14 antigen-expressing cells - Vietnam Registration 338383

Access comprehensive regulatory information for Qualitative test reagents for CD14 antigen-expressing cells in Vietnam's medical device market through Pure Global AI's free database. is registered under number 338383 and manufactured by Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences. The authorized representative in Vietnam is SISC VIETNAM EQUIPMENT JOINT STOCK COMPANY.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
1 Competitors
1 Recent Registrations
338383
Registration Details
Vietnam MOH Registration: 338383
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative test reagents for CD14 antigen-expressing cells
VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên CD14
BD CD14 (MɸP9) FITC

Registration Details

338383

BD CD14 (MɸP9) FITC

345784

Company Information

Becton, Dickinson and Company, BD Biosciences

United States

Technical Details

Lọ

Dates and Status

Dec 29, 2022

Apr 30, 2023

Hết hiệu lực

Pricing

11088000 VND

Companies Making Similar Products
Companies providing products similar to "Qualitative test reagents for CD14 antigen-expressing cells"